These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38052920)

  • 1. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
    Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
    Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer.
    Zhang L; Shen M; Zhang D; He X; Du Q; Liu N; Huang X
    J Magn Reson Imaging; 2024 Sep; 60(3):1203-1212. PubMed ID: 38088478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma.
    Chen P; Zhao S; Guo W; Shao G
    Quant Imaging Med Surg; 2023 Aug; 13(8):4816-4825. PubMed ID: 37581065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
    Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
    J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status.
    Lai B; Yi Y; Yang X; Li X; Xu L; Yan Z; Yang L; Han R; Hu H; Duan X
    Magn Reson Imaging; 2024 Oct; 112():136-143. PubMed ID: 39029603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
    Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing mesorectal tumor deposits from metastatic lymph nodes by using diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
    Xu Q; Xu Y; Wang J; Sun H; Lin J; Xie S
    Eur Radiol; 2023 Jun; 33(6):4127-4137. PubMed ID: 36520180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.
    Ao F; Yan Y; Zhang ZL; Li S; Li WJ; Chen GB
    Acta Radiol; 2022 Jul; 63(7):891-900. PubMed ID: 34134527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
    Partridge SC; Mullins CD; Kurland BF; Allain MD; DeMartini WB; Eby PR; Lehman CD
    AJR Am J Roentgenol; 2010 Jun; 194(6):1664-73. PubMed ID: 20489111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
    Chen H; Li W; Wan C; Zhang J
    Front Oncol; 2022; 12():942943. PubMed ID: 35992872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution diffusion-weighted imaging compared with conventional diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging with regard to image quality and assessment of breast cancer morphology.
    Metin Y; Orhan Metin N; Kul S; Taşçı F; Özdemir O; Küpeli A
    Diagn Interv Radiol; 2023 Mar; 29(2):251-259. PubMed ID: 36987843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
    Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.